Journal ArticleDOI
Blinding during data analysis and writing of manuscripts
About:
This article is published in Controlled Clinical Trials.The article was published on 1996-08-01. It has received 113 citations till now. The article focuses on the topics: Blinding.read more
Citations
More filters
Journal ArticleDOI
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
David Moher,Sally Hopewell,Kenneth F. Schulz,Victor M. Montori,Peter C Gøtzsche,Philip J. Devereaux,Diana Elbourne,Matthias Egger,Douglas G. Altman +8 more
TL;DR: This update of the CONSORT statement improves the wording and clarity of the previous checklist and incorporates recommendations related to topics that have only recently received recognition, such as selective outcome reporting bias.
Chapter 8: Assessing risk of bias in included studies
TL;DR: The Cochrane Handbook for Systematic Reviews of Interventions (ISBN 978-0470057964) is published by John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, West Sussex PO19 8SQ, England.
Journal ArticleDOI
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Douglas G. Altman,Kenneth F. Schulz,David Moher,Matthias Egger,Frank Davidoff,Diana Elbourne,Peter C Gøtzsche,Tom Lang +7 more
TL;DR: The Consort Statement as mentioned in this paper is a group of scientists and editors developed to improve the quality of reporting of randomized, controlled trials (RCTs) by providing guidance to authors about how to improve their reporting of their trials.
Journal ArticleDOI
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
An-Wen Chan,Jennifer Tetzlaff,Peter C Gøtzsche,Douglas G. Altman,Howard Mann,Jesse A. Berlin,Kay Dickersin,Asbjørn Hróbjartsson,Kenneth F. Schulz,Wendy R. Parulekar,Karmela Krleza-Jeric,Andreas Laupacis,David Moher,David Moher +13 more
TL;DR: The SPIRIT 2013 Explanation and Elaboration paper provides important information to promote full understanding of the checklist recommendations and strongly recommends that this explanatory paper be used in conjunction with the SPIRit Statement.
Journal ArticleDOI
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
Niklas Nielsen,Jørn Wetterslev,Tobias Cronberg,David Erlinge,Yvan Gasche,Christian Hassager,Janneke Horn,Jan Hovdenes,Jesper Kjaergaard,Michael A. Kuiper,Tommaso Pellis,Pascal Stammet,Michael Wanscher,Matt P. Wise,Anders Aneman,Nawaf Al-Subaie,Søren Boesgaard,John Bro-Jeppesen,Iole Brunetti,J. F. Bugge,Christopher D. Hingston,Nicole P. Juffermans,Matty Koopmans,Lars Køber,Jørund Langørgen,Gisela Lilja,Jacob E. Møller,Malin Rundgren,Christian Rylander,Ondrej Smid,Christophe Werer,Per Winkel,Hans Friberg,Abstr Act +33 more
TL;DR: In unconscious survivors of out-of-hospital cardiac arrest of presumed cardiac cause, hypothermia at a targetedTemperature of 33°C did not confer a benefit as compared with a targeted temperature of 36°C.
References
More filters
Journal ArticleDOI
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.
TL;DR: Empirical evidence is provided that inadequate methodological approaches in controlled trials, particularly those representing poor allocation concealment, are associated with bias.
Journal ArticleDOI
A consumer's guide to subgroup analyses.
Andrew D Oxman,Gordon H. Guyatt +1 more
TL;DR: Guidelines are provided in this paper that will assist clinicians in making decisions regarding whether to base a treatment decision on overall results or on the results of a subgroup analysis.
Journal ArticleDOI
Statistical problems in the reporting of clinical trials. A survey of three medical journals.
TL;DR: Overall, the reporting of clinical trials appears to be biased toward an exaggeration of treatment differences, and more emphasis should be given to the magnitude of treatment Differences and to estimation methods such as confidence intervals.
Journal ArticleDOI
Methodology and Overt and Hidden Bias in Reports of 196 Double-Blind Trials of Nonsteroidal Antiinflammatory Drugs in Rheumatoid Arthritis
TL;DR: Important design aspects were decreasingly reported in NSAID trials over the years, whereas the quality of statistical analysis improved, and it is not obvious how a reliable meta-analysis could be done in these trials.